HALMED invites all general practitioners, pharmacists and cardiologists to participate in the survey on HCPs' opinions and views on safety communications
The Agency for Medicinal Products and Medical Devices (HALMED) in collaboration with Croatian Society of Family Physicians (HDOD), Croatian Pharmaceutical Society (HFD) and Croatian Cardiac Society (HKD) has initiated a survey on views of healthcare professionals on how competent authorities, like HALMED in Croatia, communicate new safety issues related to use of medicines to healthcare professionals.
As a result of HALMED’s efforts, the Republic of Croatia has been chosen among other Member States to participate in conducting this survey within the SCOPE aimed at providing a possibility to healthcare professionals to express their opinions and views on safety communications. Other participating countries are Spain, United Kingdom, Ireland, Italy, Sweden, the Netherlands, Norway and Denmark. The survey is part of a broader pharmacovigilance EU project entitled SCOPE (Strengthening Collaboration for Operating Pharmacovigilance in Europe) aimed at improving the health safety of patients in the EU, by promoting co-operation among member states and providing support to medicines regulatory agencies in meeting the requirements of the EU pharmacovigilance legislation. In line with the settings of the SCOPE project, HALMED invites all general practitioners, pharmacists and cardiologists to participate in the survey as target groups.
The aim of this survey is to examine experiences of healthcare professionals with safety communication by the medicines regulatory agencies, as well as their views on the effectiveness of such communication, and to identify healthcare professionals’ preferred communication channels.
More information on the survey and direct access are available under the link below, as well as on the webpages of Croatian Society of Family Physicians (HDOD), Croatian Pharmaceutical Society (HFD) and Croatian Cardiac Society (HKD).